Basmisanil
Basmisanil (also known as RG-1662 and RO5186582) is an experimental drug candidate for the treatment of cognitive impairment associated with Down syndrome. It is being developed by Roche and is currently in Phase II clinical trials.
Mechanism of Action[edit | edit source]
Basmisanil is a negative allosteric modulator of the alpha-5 subunit of the GABA-A receptor. It is hypothesized to work by reducing the excessive inhibition in the brains of individuals with Down syndrome, thereby improving cognitive function.
Clinical Trials[edit | edit source]
Basmisanil has undergone Phase I and II clinical trials. The Phase II trial, conducted by Roche, aimed to assess the safety, tolerability, and efficacy of the drug in individuals with Down syndrome aged between 12 and 30 years. However, the results of the trial, published in 2020, showed that Basmisanil did not meet its primary endpoint of improving cognitive function.
Future Development[edit | edit source]
Despite the disappointing results of the Phase II trial, research into the potential benefits of Basmisanil continues. Roche has stated that they remain committed to exploring new treatment options for individuals with Down syndrome.
See Also[edit | edit source]
References[edit | edit source]
| Basmisanil Resources | ||
|---|---|---|
|
| |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
